ArticleCell biochemistry and function2026
Mycoplasma Contamination Alters the Expression Profile of Pro-Inflammatory Cytokines by Human Innate Immune Cells.
Article in Cell biochemistry and function, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The impact of Mycoplasma contaminations on in vitro test systems has been extensively discussed and in vitro studies have demonstrated various effects on the physiology of the contaminated cell line. Thus far, little is known about the effect of biologically active substances, such as viruses produced in contaminated cell lines on primary immune cells. Therefore, the aim of the present study was to pinpoint the impact of Mycoplasma contamination on human innate immune cells. To address this, myeloid dendritic cells (mDC) and two types of macrophages (type M1 and M2) were in vitro differentiated from healthy donors and treated with different volumes of cell-culture supernatant from Mycoplasma-contaminated VeroE6 cells (SN(M)). Depending on the cell type, Mycoplasma contamination mediated a decrease in viability and the pre-activation of the immune cells. Surprisingly, small amounts of SN(M) were sufficient to induce the secretion of massive amounts of pro-inflammatory interleukin (IL)-6 and, to a lesser extent, tumor necrosis factor (TNF)-α and interleukin (IL)-10. Moreover, SN(M) co-stimulation of cells treated with a variety of toll-like receptor (TLR) ligands and different RNA-encoded viruses differentially altered their activation status, depending on the analyzed markers, cell types, and stimuli. Furthermore, SN(M) co-treatment strongly influenced the induced cytokine profile of mDC as well as M1 and M2 macrophages upon treatment with various stimuli, especially upon viral infection. In line with this, a batch of SARS-CoV-2 produced in Mycoplasma-contaminated VeroE6 cells induced high levels of IL-6 and TNF-α while treatment with the non-contaminated virus stock did not result in expression of cytokines. Our data indicate that Mycoplasma contamination has a major impact on the experimental outcome of infection experiments using human immune cells and therefore can result in misinterpretation of experimental data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.